Indian Vaccine Market Growth, Demand and Challenges of the Key Industry Players 2024-2032

1
Indian Vaccine Market Research and Forecast
Report 2024-2032

• Format PDFEXCEL

2023 IMARC All Rights Reserved
2
About IMARC Group

• International Market Analysis Research and
  Consulting Group is a leading adviser on
  management strategy and market research
  worldwide. We partner with clients in all regions
  and industry verticals to identify their
  highest-value opportunities, address their most
  critical challenges, and transform their
  businesses.
• IMARCs information products include major
  market, scientific, economic and technological
  developments for business leaders in
  pharmaceutical, industrial, and high technology
  organizations. Market forecasts and industry
  analysis for biotechnology, advanced materials,
  chemicals, food and beverage, travel and tourism,
  nanotechnology and novel processing methods are
  at the top of the companys expertise.
• IMARCs tailored approach combines unfathomable
  insight into the dynamics of companies and
  markets with close cooperation at all levels of
  the client organization. This ensures that our
  clients achieve unmatchable competitive
  advantage, build more proficient organizations,
  and secure lasting results.

3
Report Highlight and Description

• According to the latest report by IMARC Group,
  titled "Indian Vaccine Market Industry Trends,
  Share, Size, Growth, Opportunity and Forecast
  2024-2032," the Indian vaccine market size is
  expected to exhibit a growth rate (CAGR) of 12.3
  during 2024-2032.
• Vaccine refers to a medicine that aids in
  protecting against harmful diseases. It utilizes
  the bodys natural defenses in order to build
  resistance to infections while making the immune
  system stronger. It recognizes the invading
  foreign substance, such as the virus or bacteria,
  and produces antibodies that act as a barrier to
  prevent the infections.
• It is widely available in different forms, such
  as liquids, injection shots, nasal sprays and
  pills that defend the body against bacteria and
  viruses. Some of the commonly utilized vaccines
  include live-attenuated, inactivated, subunit,
  recombinant, polysaccharide, and conjugate,
  toxoid, messenger ribonucleic acid (mRNA) and
  viral vector vaccines.
• Request for a PDF sample of this report
  https//www.imarcgroup.com/indian-vaccine-market/r
  equestsample

4
Report Description

• Indian Vaccine Market Trends
• The Indian market is primarily driven by
  significant growth in the pharmaceutical
  industry. Along with this, the increasing
  investments by private and public firms for
  improving the overall pharmaceutical
  infrastructure is creating a positive market
  outlook. Moreover, the growing prevalence of
  life-threatening diseases, such as the rapid
  outbreak of coronavirus disease (COVID-19), has
  provided a boost to the demand for vaccines
  across the country. Additionally, numerous
  initiatives undertaken by the government of India
  to administer vaccines to rural and underserved
  areas are impacting the market growth favorably.
• Furthermore, extensive research and development
  (RD) activities conducted by key players for
  vaccine development, are supporting the Indian
  vaccine industry to grow significantly. The
  market is further driven by continual
  technological advancements in production
  processes and the advent of improved cold storage
  facilities. Other factors, including continuous
  improvements in the healthcare sector, the rising
  awareness among the masses, low cost of
  production, continual developments in the supply
  chain and distribution channels, and the
  increasing number of research laboratories and
  clinical centers, are also positively influencing
  the market across India.
• View Report TOC, Figures and Tables
  https//www.imarcgroup.com/indian-vaccine-market

5
Report Segmentation

• Breakup by Monovalent and Combined Vaccines
• BCG
• HIB
• Influenza
• Varicella
• Typhoid
• Japanese Encephalitis
• Measles
• Tetanus Toxoid
• Hepatitis A
• Rubella
• Diphtheria
• Tetanus, and Pertussis (DPT)

6
Report Segmentation

• Oral Polio Vaccine (OPV)
• MMR
• Rotavirus
• Hepatitis B
• Pneumococcal
• Meningococcal
• Rabies
• HPV
• Hexavalent
• Dengue vaccines

7
Competitive Landscape with Key Players

• GlaxoSmithKline
• Sanofi Aventis
• Serum Institute of India
• Panacea Biotec
• Pfizer
• Novartis
• VHB Lifesciences
• Zydus Cadila
• MSD.

8
Key Questions Answered in the Report
9
Table of Contents

• 1    Preface2    Scope and Methodology    2.1  
   Objectives of the Study    2.2  
   Stakeholders    2.3    Data Sources       
  2.3.1    Primary Sources        2.3.2  
   Secondary Sources    2.4    Market Estimation 
        2.4.1    Bottom-Up Approach        2.4.2  
   Top-Down Approach    2.5    Forecasting
  Methodology3    Executive Summary4  
   Introduction    4.1    Overview    4.2    Key
  Industry Trends5    Indian Vaccine Industry   
  5.1 Market Overview    5.2 Market Performance 
        5.2.1 Volume Trends        5.2.2 Value
  Trends    5.3 Impact of COVID-19    5.4 Market
  Breakup by Segment    5.5 Market Forecast     
    5.5.1 Volume Trends        5.5.2 Value
  Trends6   Market Analysis of Various Monovalent
  and Combined Vaccines    6.1 BCG Vaccine
  Market        6.1.1 Vaccine Overview       
  6.1.2 Market Performance       

10
Table of Contents

•         6.1.3 Market Breakup by Prescriber     
    6.1.4 Market Breakup by Public and Private
  Sector        6.1.5 Market Forecast    6.2 HIB
  Vaccine Market        6.2.1 Vaccine Overview   
      6.2.2 Market Performance        6.2.3 Market
  Breakup by Prescriber        6.2.4 Market
  Breakup by Public and Private Sector       
  6.2.5 Market Forecast    6.3 Influenza Vaccine
  Market        6.3.1 Vaccine Overview       
  6.3.2 Market Performance        6.3.3 Market
  Breakup by Prescriber        6.3.4 Market
  Breakup by Public and Private Sector       
  6.3.5 Market Forecast    6.4 Varicella Vaccine
  Market        6.4.1 Vaccine Overview       
  6.4.2 Market Performance        6.4.3 Market
  Breakup by Prescriber        6.4.4 Market
  Breakup by Public and Private Sector       
  6.4.5 Market Forecast    6.5 Typhoid Vaccine
  Market        6.5.1 Vaccine Overview       
  6.5.2 Market Performance        6.5.3 Market
  Breakup by Prescriber        6.5.4 Market
  Breakup by Public and Private Sector       
  6.5.5 Market Forecast
• For more information, visit https//www.imarcgrou
  p.com/indian-vaccine-market/toc

11
Disclaimer

• 2023 IMARC All Rights Reserved
• This Publication and all its contents unless
  otherwise mentioned are copyrighted in the name
  of International Market Analysis Research and
  Consulting (IMARC). No part of this publication
  may be reproduced, repackaged, redistributed or
  resold in whole or in any part. The publication
  may also not be used in any form or by and means
  graphic electronic or mechanical, including
  photocopying, recording, taping or by information
  storage or retrieval, or by any other form,
  without the express consent of International
  Market Analysis Research and Consulting (IMARC).
• Disclaimer All contents and data of this
  publication, including forecasts, data analysis
  and opinion have been based on information and
  sources believed to be accurate and reliable at
  the time of publishing. International Market
  Analysis Research and Consulting makes no
  representation of warranty of any kind as to the
  accuracy or completeness of any Information
  provided. IMARC accepts no liability whatsoever
  for any loss or damage resulting from opinion,
  errors or inaccuracies if any found this
  publication.
• IMARC, IMARC Group and Global Therapy Insight
  Series are registered trademarks of International
  Market Analysis Research and Consulting. All
  other trademarks used in this publication are
  registered trademarks of their respective
  companies.

12
Contact Us
Visit us at
https//www.imarcgroup.com
TELEPHONE [phone] E-MAIL
sales_at_imarcgroup.com